Hospitals | November 15, 2021
Wadia Hospital, Mumbai introduces tests for cystic fibrosis
This test is inexpensive and results are available immediately as compared to the genetic test
This test is inexpensive and results are available immediately as compared to the genetic test
The European Commission (EC) granted marketing authorisation for Celltrion’s regdanvimab following a positive opinion by the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) last week
The rise in cases amongst the young is a cause for concern. A few specialists gave us a perspective on the issue
The interim data combines three mRNAs into one therapy injected directly into the tumour
The ground-breaking project, led by Genomics England and NHS England, was established in 2013 to sequence 100,000 whole genomes from NHS patients and their families
The new manufacturing facility will be built at a subsidiary of Adcock Ingram and will commence operation in March 23
The process is completed with the help of a balloon at a low temperature so that other cells are undamaged and the patient can return home the next day
It is the first U.S. FDA approved novel topical mechanism for acne in nearly 40 years
The acquisition expands Takeda’s immuno-oncology and innate immune cell therapy portfolio with novel platforms leveraging T cells for the potential treatment of solid tumours and haematological malignancies
It has exercised intellectual property options from IP Group regarding research results generated by the UK Cystic Fibrosis Gene Therapy Consortium, and from Oxford Biomedica regarding their lentiviral vector technology
Subscribe To Our Newsletter & Stay Updated
